Biocon Limited Logo

Biocon Limited (BIOCON)

BSE

Currency in INR
370.90
-0.10 (-0.03%)

Closed

Oct 1, 2026

Day's Range

363.55
374.20

52 wk Range

337.95
447.00

Overview - BIOCON - Biocon Limited

Key Statistics

Valuation

Enterprise Value

742.08B

P/E (Trailing)

‪108.76‬

P/E (Forward)

‪34.08‬

PEG Ratio

‪0.46‬

Price / Sales (TTM)

‪3.50‬

Price / Book

‪1.76‬

EV / EBITDA

‪20.71‬

Profitability

Gross Margin

‪65.80%‬

Profit Margin

‪2.86%‬

Operating Margin

‪6.91%‬

Return on Assets

‪0.60%‬

Return on Equity

‪1.05%‬

Ownership

Shares Outstanding

1.63B

Float

806.22M

Held by Insiders

‪48.11%‬

Held by Institutions

‪30.54%‬

Price stats

Beta

‪0.30‬

50-Day Avg

‪407.02‬

200-Day Avg

‪395.02‬

Dividends

Payout Ratio

‪14.58%‬

Analyst Consensus

Hold

18 analysts

Average price target

‪₹ 446.89‬

News Teaser - BIOCON - Biocon Limited

News & Analysis

View all news

Market Cap - BIOCON - Biocon Limited

Peers - BIOCON - Biocon Limited

Peer Comparison

Compared with companies in Biotechnology listed on BSE.

Profile Summary - BIOCON - Biocon Limited

About

Biocon Limited is a biopharmaceutical company engaged in the research, development, and manufacturing of pharmaceutical products. The company is known for its focus on innovating affordable therapies for chronic conditions in areas like oncology, diabetes, and autoimmune diseases. A key aspect of Biocon's operations…

SectorHealthcare
IndustryBiotechnology
Employees16.44K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.